Abstract
Adrenoleukodystrophy (ALD) is an X-linked peroxisomal neurometabolic disorder caused by pathogenic variants in the ABCD1 gene, resulting in impaired peroxisomal ß-oxidation and accumulation of very long-chain fatty acids (VLCFA). ALD clinical presentation is heterogeneous and unpredictable, including progressive spinal cord axonal degeneration, adrenal insufficiency, and leukodystrophy. Although VLCFA accumulation represents a clear biochemical hallmark of ALD, the cellular and molecular mechanisms linking this metabolic defect to the diverse
| Original language | English |
|---|---|
| Qualification | Doctor of Philosophy |
| Awarding Institution |
|
| Supervisors/Advisors |
|
| Award date | 12 Jun 2026 |
| Print ISBNs | 9789465343884 |
| Publication status | Published - 2026 |
Fingerprint
Dive into the research topics of 'Breaking down ALD Investigating pathomechanisms using hiPSC-derived CNS models'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver